J. Goldman & CO LP Cara Therapeutics, Inc. Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $820,644 - $1.6 Million	-89,983 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $1.45 Million - $2.34 Million	89,983 New	89,983 $1.45 Million
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $628,594 - $766,899	-35,554 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$14.41 - $19.64 $512,333 - $698,280	35,554 New	35,554 $698,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.